RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4127
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0926700; Gene model (P.falciparum): PF3D7_1121600; Gene product: exported protein 1 | circumsporozoite-related antigen | parasitophorous vacuole membrane antigen QF 116 (EXP1; CRA; Ag5.1; HEP17)
Details mutation: The C2 terminal region (93 bp) of the exp1 gene deleted
Transgene
Transgene not Plasmodium: GFP (gfp-mu3)
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Liver stage;
Last modified: 5 February 2017, 11:18
  *RMgm-4127
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 28115054
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 507cl1 (RMgm-7)
Other information parent lineP.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
The mutant parasite was generated by
Name PI/ResearcherKlug D, Frischknecht F
Name Group/DepartmentIntegrative Parasitology
Name InstituteCenter for Infectious Diseases, Heidelberg University Medical School
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-4127
Principal namePbEXP-1ΔC2
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageThe mutant expressing the mutated form of EXP1 lacking the C2 terminal region has a normal development of blood stages. Evidence is presented for normal sporozoite production and invasion of hepatocytes by sporozoites. Liver stage development of the mutant is impaired resulting in significant reduction of 'late liver stage' parasite loads and delayed blood-stage patency.
Additional remarks phenotype

Mutant/mutation
The mutant expresses a mutated version of EXP1; the C2 terminal region (93 bp) of the exp1 gene is deleted. In addition it expresses GFP under control of the eef1a constitutive promoter

Protein (function)
Exp1 (HEP17; circumsporozoite-related antigen) is a protein that localizes to the parasitophorous vacuole membrane (PVM) of blood stages and liver stages

Phenotype
Unsuccessful attempts to disrupt the exp1 indicates an essential function for blood stage development (see RMgm-4125).
The mutant expressing the mutated form of EXP1 lacking the C2 terminal region has a normal development of blood stages. Liver stage development of the mutant is impaired resulting in significant reduction of 'late liver stage' parasite loads and delayed blood-stage patency.

Evidence is presented that:
The characteristic movement of infectious sporozoites and their invasion capacity were not impaired in the PbEXP-1ΔC2 parasites. Additionally, immunofluorescence microscopy analysis of Huh7 cells infected with clonal PbEXP-1ΔC2 lines and stained with antibodies against the PVM proteins UIS4 and EXP-1 indicated that neither the integrity of the vacuolar membrane nor the localization of EXP-1 were compromised in transgenic parasites. Evidence is presented for reduced 'late-liver stage' parasite loads in liver of mice infected with the mutant.

Additional information
EXP1 is located in the PVM. Evidence is presented that the C-terminal domain of EXP-1 faces the hepatocyte cytoplasm.
Evidence is presented that the C2-terminal region of EXP1 interacts with the host protein  Apolipoprotein H (ApoH). It is suggested that Plasmodium liver stages use EXP-1 to specifically recruit host–hepatocyte ApoH to the parasite–host interface and to potentially mediate uptake of ApoH and/or ApoH-associated proteins or lipids.

Other mutants
See EXP1 for other mutants
 


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0926700
Gene Model P. falciparum ortholog PF3D7_1121600
Gene productexported protein 1 | circumsporozoite-related antigen | parasitophorous vacuole membrane antigen QF 116
Gene product: Alternative nameEXP1; CRA; Ag5.1; HEP17
Details of the genetic modification
Short description of the mutationThe C2 terminal region (93 bp) of the exp1 gene deleted
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationTo generate the PbEXP-1ΔC2 parasite line, a 3′ UTR fragment was amplified by using 3′ PbEXP-1 for and 3′ PbEXP1 rev primers, and a 5′fragment including the ORF without the last 93 bp of PbEXP-1 was amplified with 5′ PbEXP-1ORFdC2 for and 5′ PbEXP1ORFdC2 rev primers from Pb WT genomic DNA (gDNA) and cloned into the b3D+ vector
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP (gfp-mu3)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe GFP gene (1 copy) has been inserted into the 230p locus (PBANKA_030600) by double cross-over integration.
Additional remarks selection procedureThis reporter mutant expressing GFP does not contain a drug-selectable marker. This mutant has been selected by FACS sorting after transfection based on GFP fluorescence.
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4